IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Department of Medical Genetics, Life Science Institute, University of British Columbia, Vancouver, BC, Canada.
Commun Biol. 2020 Jul 3;3(1):342. doi: 10.1038/s42003-020-1072-4.
Protein-based affinity reagents (like antibodies or alternative binding scaffolds) offer wide-ranging applications for basic research and therapeutic approaches. However, whereas small chemical molecules efficiently reach intracellular targets, the delivery of macromolecules into the cytosol of cells remains a major challenge; thus cytosolic applications of protein-based reagents are rather limited. Some pathogenic bacteria have evolved a conserved type III secretion system (T3SS) which allows the delivery of effector proteins into eukaryotic cells. Here, we enhance the T3SS of an avirulent strain of Salmonella typhimurium to reproducibly deliver multiple classes of recombinant proteins into eukaryotic cells. The efficacy of the system is probed with both DARPins and monobodies to functionally inhibit the paradigmatic and largely undruggable RAS signaling pathway. Thus, we develop a bacterial secretion system for potent cytosolic delivery of therapeutic macromolecules.
基于蛋白质的亲和试剂(如抗体或替代结合支架)为基础研究和治疗方法提供了广泛的应用。然而,尽管小分子化学物质能够有效地到达细胞内靶点,但将大分子递送到细胞质仍然是一个主要的挑战;因此,基于蛋白质的试剂在细胞质中的应用相当有限。一些致病性细菌已经进化出一种保守的 III 型分泌系统(T3SS),允许将效应蛋白递送到真核细胞中。在这里,我们增强了无毒鼠伤寒沙门氏菌的 T3SS,以可重复的方式将多种类别的重组蛋白递送到真核细胞中。该系统的功效通过 DARPins 和单域抗体进行了探测,以功能上抑制典范且在很大程度上不可成药的 RAS 信号通路。因此,我们开发了一种细菌分泌系统,用于有效递送至细胞质的治疗性大分子。